{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:06:22Z","timestamp":1764403582852,"version":"3.46.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00690-5","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T13:25:49Z","timestamp":1761398749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pyrimidin-4-bromobenzenesulfonamide\/-4-nitrobenzenesulfonamide hybrids as potential BRAFV600E inhibitors: experimental, computational and biological evaluations"],"prefix":"10.1007","volume":"39","author":[{"given":"Ankit Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshwardhan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Martinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prateek","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mubashra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurica","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"690_CR1","doi-asserted-by":"publisher","first-page":"27819","DOI":"10.1021\/acsomega.3c00332","volume":"8","author":"AK Singh","year":"2023","unstructured":"Singh AK, Sonawane P, Kumar A, Singh H, Naumovich V, Pathak P, Grishina M, Khalilullah H, Jaremko M, Emwas A-H (2023) Challenges and opportunities in the crusade of BRAF inhibitors: from 2002 to 2022. ACS Omega 8:27819\u201327844","journal-title":"ACS Omega"},{"key":"690_CR2","first-page":"1997","volume":"19","author":"Y-J Guo","year":"2020","unstructured":"Guo Y-J, Pan W-W, Liu S-B, Shen Z-F, Xu Y, Hu L-L (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19:1997\u20132007","journal-title":"Exp Ther Med"},{"key":"690_CR3","doi-asserted-by":"publisher","first-page":"11752","DOI":"10.18632\/oncotarget.2555","volume":"5","author":"E Oikonomou","year":"2014","unstructured":"Oikonomou E, Koustas E, Goulielmaki M, Pintzas A (2014) BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications. Oncotarget 5:11752","journal-title":"Oncotarget"},{"key":"690_CR4","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.3390\/cancers15164026","volume":"15","author":"G Castellani","year":"2023","unstructured":"Castellani G, Buccarelli M, Arasi MB, Rossi S, Pisanu ME, Bellenghi M, Lintas C, Tabolacci C (2023) BRAF mutations in melanoma: biological aspects, therapeutic implications, and circulating biomarkers. Cancers 15:4026","journal-title":"Cancers"},{"key":"690_CR5","doi-asserted-by":"publisher","first-page":"10862","DOI":"10.1080\/07391102.2021.1950571","volume":"40","author":"S Chatterjee","year":"2022","unstructured":"Chatterjee S, Chakraborty R, Hasija Y (2022) Polymorphisms at site 469 of BRAF protein associated with skin melanoma may be correlated with dabrafenib resistance: an in silico study. J Biomol Struct Dyn 40:10862\u201310877","journal-title":"J Biomol Struct Dyn"},{"key":"690_CR6","doi-asserted-by":"crossref","unstructured":"Ritterhouse LL and Barletta JA (2015) BRAFV600E mutation-specific antibody: a review. Seminars in diagnostic pathology, Elsevier, pp. 400\u2013408.","DOI":"10.1053\/j.semdp.2015.02.010"},{"key":"690_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12032-016-0879-9","volume":"34","author":"J Cicenas","year":"2017","unstructured":"Cicenas J, Tamosaitis L, Kvederaviciute K, Tarvydas R, Staniute G, Kalyan K, Meskinyte-Kausiliene E, Stankevicius V, Valius M (2017) KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Med Oncol 34:26","journal-title":"Med Oncol"},{"key":"690_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/1871520622666220624164152","volume":"23","author":"AK Singh","year":"2023","unstructured":"Singh AK, Kumar A, Thareja S, Kumar P (2023) Current insights into the role of BRAF inhibitors in treatment of melanoma. Anti-Cancer Agents Med Chem 23:278\u2013297","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"690_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s40265-013-0095-2","volume":"73","author":"AD Ballantyne","year":"2013","unstructured":"Ballantyne AD, Garnock-Jones KP (2013) Dabrafenib: first global approval. Drugs 73:1367\u20131376","journal-title":"Drugs"},{"key":"690_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1470-2045(18)30142-6","volume":"19","author":"R Dummer","year":"2018","unstructured":"Dummer R, Ascierto PA, Gogas HJ, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R (2018) Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 19:603\u2013615","journal-title":"Lancet Oncol"},{"key":"690_CR11","doi-asserted-by":"crossref","unstructured":"Garbe C and Eigentler TK (2018) Vemurafenib. Small molecules in Oncology:77\u201389.","DOI":"10.1007\/978-3-319-91442-8_6"},{"key":"690_CR12","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/cancers12102801","volume":"12","author":"I Proietti","year":"2020","unstructured":"Proietti I, Skroza N, Bernardini N, Tolino E, Balduzzi V, Marchesiello A, Michelini S, Volpe S, Mambrin A, Mangino G (2020) Mechanisms of acquired BRAF inhibitor resistance in melanoma: a systematic review. Cancers (Basel) 12:2801","journal-title":"Cancers (Basel)"},{"key":"690_CR13","doi-asserted-by":"publisher","first-page":"30181","DOI":"10.1039\/D2RA05751D","volume":"12","author":"AK Singh","year":"2022","unstructured":"Singh AK, Novak J, Kumar A, Singh H, Thareja S, Pathak P, Grishina M, Verma A, Yadav JP, Khalilullah H (2022) Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine\u2013sulfonamide hybrids as selective BRAFV600E inhibitors. RSC Adv 12:30181\u201330200","journal-title":"RSC Adv"},{"key":"690_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nsmb.2924","volume":"22","author":"N Thevakumaran","year":"2015","unstructured":"Thevakumaran N, Lavoie H, Critton DA, Tebben A, Marinier A, Sicheri F, Therrien M (2015) Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation. Nat Struct Mol Biol 22:37\u201343","journal-title":"Nat Struct Mol Biol"},{"key":"690_CR15","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1038\/s41388-020-1263-y","volume":"39","author":"T Brummer","year":"2020","unstructured":"Brummer T, McInnes C (2020) RAF kinase dimerization: implications for drug discovery and clinical outcomes. Oncogene 39:4155\u20134169","journal-title":"Oncogene"},{"key":"690_CR16","doi-asserted-by":"publisher","first-page":"D361","DOI":"10.1093\/nar\/gky916","volume":"47","author":"R Rahman","year":"2019","unstructured":"Rahman R, Ung PM-U, Schlessinger A (2019) KinaMetrix: a web resource to investigate kinase conformations and inhibitor space. Nucleic Acids Res 47:D361\u2013D366","journal-title":"Nucleic Acids Res"},{"key":"690_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1021\/acs.jctc.2c01171","volume":"19","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu Y, Jang H, Nussinov R (2023) Strategy toward kinase-selective drug discovery. J Chem Theory Comput 19:1615\u20131628","journal-title":"J Chem Theory Comput"},{"key":"690_CR18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.bmcl.2007.11.038","volume":"18","author":"MK Parai","year":"2008","unstructured":"Parai MK, Panda G, Srivastava K, Puri SK (2008) Design, synthesis and antimalarial activity of benzene and isoquinoline sulfonamide derivatives. Bioorg Med Chem Lett 18:776\u2013781","journal-title":"Bioorg Med Chem Lett"},{"key":"690_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ejmech.2015.01.036","volume":"92","author":"MM Ghorab","year":"2015","unstructured":"Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, Zahran SS (2015) Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. Eur J Med Chem 92:682\u2013692","journal-title":"Eur J Med Chem"},{"key":"690_CR20","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1021\/acschembio.6b00529","volume":"11","author":"M Grasso","year":"2016","unstructured":"Grasso M, Estrada MA, Ventocilla C, Samanta M, Maksimoska J, Villanueva J, Winkler JD, Marmorstein R (2016) Chemically linked vemurafenib inhibitors promote an inactive BRAFV600E conformation. ACS Chem Biol 11:2876\u20132888","journal-title":"ACS Chem Biol"},{"key":"690_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"690_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A \u0160ali","year":"1993","unstructured":"\u0160ali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779\u2013815","journal-title":"J Mol Biol"},{"key":"690_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1471-2105-7-339","volume":"7","author":"EC Meng","year":"2006","unstructured":"Meng EC, Pettersen EF, Couch GS, Huang CC, Ferrin TE (2006) Tools for integrated sequence-structure analysis with UCSF chimera. BMC Bioinf 7:339","journal-title":"BMC Bioinf"},{"key":"690_CR24","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"690_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13321-014-0037-3","volume":"6","author":"P Tosco","year":"2014","unstructured":"Tosco P, Stiefl N, Landrum G (2014) Bringing the MMFF force field to the RDKit: implementation and validation. J Cheminf 6:37","journal-title":"J Cheminf"},{"key":"690_CR26","first-page":"5281","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum G (2013) RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum 8:5281","journal-title":"Greg Landrum"},{"key":"690_CR27","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"690_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graphics Modell 25:247\u2013260","journal-title":"J Mol Graphics Modell"},{"key":"690_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174","journal-title":"J Comput Chem"},{"key":"690_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2019","unstructured":"Tian C, Kasavajhala K, Belfon KA, Raguette L, Huang H, Migues AN, Bickel J, Wang Y, Pincay J, Wu Q (2019) ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16:528\u2013552","journal-title":"J Chem Theory Comput"},{"key":"690_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/jcc.540110404","volume":"11","author":"BH Besler","year":"1990","unstructured":"Besler BH, Merz KM Jr, Kollman PA (1990) Atomic charges derived from semiempirical methods. J Comput Chem 11:431\u2013439","journal-title":"J Comput Chem"},{"key":"690_CR32","doi-asserted-by":"publisher","first-page":"W522","DOI":"10.1093\/nar\/gkm276","volume":"35","author":"TJ Dolinsky","year":"2007","unstructured":"Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35:W522\u2013W525","journal-title":"Nucleic Acids Res"},{"key":"690_CR33","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1021\/acs.jctc.9b00953","volume":"16","author":"MR Machado","year":"2020","unstructured":"Machado MR, Pantano S (2020) Split the charge difference in two! A rule of thumb for adding proper amounts of ions in MD simulations. J Chem Theory Comput 16:1367\u20131372","journal-title":"J Chem Theory Comput"},{"key":"690_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0021-9991(83)90014-1","volume":"52","author":"HC Andersen","year":"1983","unstructured":"Andersen HC (1983) Rattle: A \u201cvelocity\u201d version of the shake algorithm for molecular dynamics calculations. J Comput Phys 52:24\u201334","journal-title":"J Comput Phys"},{"key":"690_CR35","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N log (N) method for Ewald sums in large systems. J Chem Phy 98:10089\u201310089","journal-title":"J Chem Phy"},{"key":"690_CR36","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1021\/jacs.9b11433","volume":"142","author":"VWD Cruzeiro","year":"2020","unstructured":"Cruzeiro VWD, Feliciano GT, Roitberg AE (2020) Exploring coupled redox and pH processes with a force-field-based approach: applications to five different systems. J Am Chem Soc 142:3823\u20133835","journal-title":"J Am Chem Soc"},{"key":"690_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461","journal-title":"Expert Opin Drug Discov"},{"key":"690_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Rio AD, Degliesposti G, Sgobba M (2010) Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem 31:797\u2013810","journal-title":"J Comput Chem"},{"key":"690_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejmech.2014.11.008","volume":"90","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Xin B-T, Zhang Y, Wu J, Lu X, Zheng Y, Tang W, Zhou X (2015) Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents. Eur J Med Chem 90:170\u2013183","journal-title":"Eur J Med Chem"},{"key":"690_CR40","doi-asserted-by":"publisher","first-page":"11812","DOI":"10.1080\/07391102.2023.2265486","volume":"42","author":"T Ram","year":"2024","unstructured":"Ram T, Singh AK, Pathak P, Kumar A, Singh H, Grishina M, Novak J, Kumar P (2024) Design, one-pot synthesis, computational and biological evaluation of diaryl benzimidazole derivatives as MEK inhibitors. J Biomol Struct Dyn 42:11812\u201311827","journal-title":"J Biomol Struct Dyn"},{"key":"690_CR41","doi-asserted-by":"publisher","first-page":"1900053","DOI":"10.1002\/ardp.201900053","volume":"352","author":"P Pathak","year":"2019","unstructured":"Pathak P, Naumovich V, Grishina M, Shukla PK, Verma A, Potemkin V (2019) Quinazoline based 1, 3, 5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: design, synthesis, docking, and QSAR study. Arch Pharm 352:1900053","journal-title":"Arch Pharm"},{"key":"690_CR42","doi-asserted-by":"publisher","first-page":"27355","DOI":"10.1039\/D2RA03624J","volume":"12","author":"AY Khormi","year":"2022","unstructured":"Khormi AY, Farghaly TA, Bayazeed A, Al-Ghamdi YO, Abdulwahab HG, Shaaban MR (2022) Novel thiazole derivatives incorporating phenyl sulphonyl moiety as potent BRAFV600E kinase inhibitors targeting melanoma. RSC Adv 12:27355\u201327369","journal-title":"RSC Adv"},{"key":"690_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.32604\/or.2022.025187","volume":"29","author":"FH Tobeigei","year":"2022","unstructured":"Tobeigei FH, Gahtani RM, Shaikh A, Al Ali A, Kameli N, Kamli H, Rajagopalan P (2022) Computational high-throughput screening and in vitro approaches identify CB-006-3; a novel PI3K-BRAFV600E dual targeted inhibitor against melanoma. Oncol Res 29:305","journal-title":"Oncol Res"},{"key":"690_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","volume":"36","author":"Y-C Chen","year":"2015","unstructured":"Chen Y-C (2015) Beware of docking! Trends Pharmacol Sci 36:78\u201395","journal-title":"Trends Pharmacol Sci"},{"key":"690_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.apcsb.2015.09.004","volume":"102","author":"P Sneha","year":"2016","unstructured":"Sneha P, Doss CGP (2016) Molecular dynamics: new frontier in personalized medicine. Adv Protein Chem Struct Biol 102:181\u2013224","journal-title":"Adv Protein Chem Struct Biol"},{"key":"690_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva N, Galzitskaya O (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628","journal-title":"Mol Biol"},{"key":"690_CR47","doi-asserted-by":"publisher","first-page":"13547","DOI":"10.1080\/07391102.2021.1990131","volume":"40","author":"S Kandagalla","year":"2022","unstructured":"Kandagalla S, Novak J, Shekarappa SB, Grishina MA, Potemkin VA, Kumbar B (2022) Exploring potential inhibitors against Kyasanur forest disease by utilizing molecular dynamics simulations and ensemble docking. J Biomol Struct Dyn 40:13547\u201313563","journal-title":"J Biomol Struct Dyn"},{"key":"690_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4155\/fmc-2020-0248","volume":"13","author":"J Novak","year":"2021","unstructured":"Novak J, Rimac H, Kandagalla S, Grishina MA, Potemkin VA (2021) Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database. Future Med Chem 13:363\u2013378","journal-title":"Future Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00690-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:02:07Z","timestamp":1764403327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00690-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00690-5","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction in data availability statement.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"108"}}